|Description||OD-36, a macrocycle compound, has been found to be a RIPK2 inhibitor that could decrease cellular infiltration induced by MDP in neutrophils and lymphocytes. IC50: 5.3nM.|
|Appearance||Light Beige Powder|
|Synonyms||OD36; OD-36; OD 36; 6-Chloro-10,11,14,17-tetrahydro-13H-1,16-etheno-4,8-metheno-1H-pyrazolo[3,4-g][1,14,4,6]dioxadiazacyclohexadecine|
|Storage||Store in a cool and dry place and at 0 - 4 °C for short term (days to weeks) or -20 °C for long term (months to years).|
|Quality Standard||In-house standard|
GSK2982772, with potential effect to treat inflammatory diseases, potently binds to RIP1 with exquisite kinase specificity. In phase 2a clinical studies for pso...
RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) (IC50= 13 nM), and efficiently reduced tumor ...
GSK'872 is aRIPK3inhibitor, which binds RIP3 kinase domain with high affinity (IC50=1.8 nM), and is approximately >1,000-fold selective over 300 kinases in a fl...
GSK481 is a potent inhibitor of Receptor-interacting serine/threonine-protein kinase 1 (RIPK1 or RIP1; IC50 value 2.8 nM for inhibition of Ser166 autophosphoryl...
OD-36, a macrocycle compound, has been found to be a RIPK2 inhibitor that could decrease cellular infiltration induced by MDP in neutrophils and lymphocytes. IC...
WEHI-345, a pyrazolo-pyridine derivative, is a RIPK2 inhibitor and has been found to influence the production of inflammatory cytokine. IC50: 0.13 μM.